ESR1 and breast cancer: Basal-like breast cancer (BLBC) is a specific category of invasive BC, and most BLBC are triple-negative breast cancers (TNBC), which are negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2).